The First Korean Patient With Severe Aortic Stenosis and Bilateral Iliofemoral Artery Disease Treated With Transcatheter Aortic Valve Implantation by Transsubclavian Approach.
10.4070/kcj.2012.42.11.796
- Author:
Seung Jun LEE
1
;
Young Guk KO
;
Ji Young SHIM
;
Sak LEE
;
Byung Chul CHANG
;
Jae Kwang SHIM
;
Young Ran KWAK
;
Myeong Ki HONG
Author Information
1. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea. mkhong61@yuhs.ac
- Publication Type:Case Report
- Keywords:
Aortic valve stenosis;
Catheters;
Heart valve prosthesis;
Prosthesis implantation
- MeSH:
Aorta;
Aortic Valve;
Aortic Valve Stenosis;
Arteries;
Catheters;
Femoral Artery;
Heart Valve Prosthesis;
Humans;
Peripheral Arterial Disease;
Prevalence;
Prosthesis Implantation;
Thoracotomy
- From:Korean Circulation Journal
2012;42(11):796-799
- CountryRepublic of Korea
- Language:English
-
Abstract:
Transcatheter aortic valve implantation (TAVI) is indicated as an alternative treatment modality to surgical aortic valve replacement for high risk patients. The standard retrograde approach through the femoral artery is not feasible in the case of unfavorable iliofemoral anatomy or severe peripheral arterial disease (PAD). However, patients with aortic stenosis (AS) have a higher prevalence of for PAD because both diseases are consequences of atherosclerotic degenerative changes. Transsubclavian, transapical, and direct access to the ascending aorta by thoracotomy are alternative routes for the TAVI procedure. In this report, we present the first Korean patient with symptomatic severe AS and bilateral iliofemoral artery disease who was successfully treated with TAVI using a CoreValve (Medtronic, Minneapolis, MN, USA) by transsubclavian approach.
